Rationale: During reperfusion of ischemic myocardium, a burst of hydroxyl radicals (Ȯ H) induces contractile dysfunction ("myocardial stunning"), and Ȯ H in the plasma of patients after myocardial infarction predict the development of heart failure. The effects of Ȯ H on myocardial function in patients with heart failure; however, have never been assessed. Furthermore, although ATP-dependent K ؉ channels (K ATP channels) are implicated in myocardial protection during ischemia/reperfusion ("ischemic preconditioning"), their role in heart failure has hardly been elucidated. Objective: To investigate the effects of Ȯ H on cardiac contractile function in human failing myocardium, and to clarify the role of K ATP channels during this response. Methods and Results: In isolated left ventricular trabeculae of nonfailing hearts, Ȯ H (produced by Fe 3؉nitrilotriacetic acid and H 2 O 2 ) induced substantial systolic and diastolic dysfunction, whereas in failing myocardium, stunning was virtually absent. Although in failing myocardium, protein expression of sarcolemmal K ATP channels (Kir6.2/SUR2) was Ϸ2-fold upregulated, their blockade with HMR-1098 did not impair contractile function in the presence of Ȯ H. In contrast, when blocking mitochondrial K ATP channels during Ȯ H exposure (with 5-HD), failing myocardium developed contractile dysfunction to a degree that was comparable to Ȯ H-induced stunning in nonfailing myocardium without K ATP channel blockade. Conclusions: Human failing left ventricular myocardium is resistant to Ȯ H-induced stunning, and this resistance is related to endogenous activation of putative mitochondrial K ATP channels. Given that certain sulfonylurea drugs that also block mitochondrial K ATP channels (eg, glibenclamide) are frequently used for the treatment of diabetes, our results imply that in patients with heart failure and diabetes, these drugs may impair left ventricular function during ischemia/reperfusion. (Circ Res. 2009;105:811-817.)
R eactive oxygen species (ROS) play a central role in myocardial reperfusion injury, 1,2 hypertrophy, and failure. 3 The reperfusion of ischemic myocardium induces a burst-like release of superoxide (O 2 Ϫ) from the electron transport chain (ETC). 1,2 O 2 Ϫ is dismutated to hydrogen peroxide (H 2 O 2 ) and further transformed to hydroxyl radicals (Ȯ H). 1, 3 These ROS (that occur also extracellularly 1, 4 ) induce cytosolic Ca 2ϩ overload and decrease myofilament Ca 2ϩsensitivity. 2, [5] [6] [7] Although the burst of ROS during reperfusion lasts only several minutes, systolic and diastolic function remain impaired for several hours, a phenomenon termed "myocardial stunning." 2 A central role in ischemia/reperfusion damage is played by mitochondria. During reperfusion, cytosolic Ca 2ϩ overload triggers mitochondrial Ca 2ϩ accumulation, which, together with ROS, opens the mitochondrial permeability transition pore (MPTP). 8 This dissipates the mitochondrial membrane potential (⌬⌿ m ), releases cytochrome c to the cytosol, and induces apoptosis or necrosis. 8 In animal models, oxidative stress and apoptosis have been causally linked to the progression of contractile dysfunction to overt heart failure. 3 Indeed, in patients with myocardial infarction, elevated plasma levels of Ȯ H at discharge predicted the development of heart failure. 9 The effects of Ȯ H in human failing myocardium, however, have never been explored. Animal models suggested a higher susceptibility of failing myocytes to oxidative stress. 10, 11 In contrast to these predictions, however, we report here that compared to human nonfailing (NF) myocardium, failing myocardium is remarkably resistant to Ȯ H-induced stunning. Because this is unlikely the result of increased antioxidative capacity, 12, 13 we searched for alternative explanations for this unanticipated finding.
Ischemic preconditioning (IPC) refers to the ability of the heart to be protected from an ischemic insult by preceding episodes of ischemia/reperfusion. 14 -18 Although the detailed mechanisms of IPC are not completely resolved yet, 14, 15 according to many present concepts, ATP-dependent K ϩ channels (K ATP channels) play an important role in IPC. 16 -18 One controversial issue is whether IPC is mediated by sarcolemmal (sarcK ATP ) or mitochondrial (mitoK ATP ) K ATP channels or both. 16 -18 Whereas activation of sarcK ATP reduces cytosolic Ca 2ϩ overload by hyperpolarizing the resting membrane potential during ischemia, activation of mitoK ATP prevents mitochondrial Ca 2ϩ overload and consequently, activation of the MPTP. 16 -18 Given that in heart failure, oxidative stress is increased, 9, 19 and ROS are able to open mitoK ATP 20 and sarcK ATP 21 and trigger IPC, 22 we speculated that this may result in endogenous protection of human failing myocardium from Ȯ H-induced stunning.
Methods
An expanded Methods section, which includes more detailed information about Western blot analysis, aconitase activity, and real-time polymerase chain reaction, is available in the Online Data Supplement at http://circres.ahajournals.org.
Human Myocardium
The study was approved by the local ethics committee (Ä rztekammer des Saarlandes no. 131/00), and all patients gave informed consent. Experiments were performed on human left ventricular (LV) myocardium obtained from 31 patients with either ischemic (ICM) or dilated (DCM) cardiomyopathy (see the Table for patient characteristics). Fifteen donor hearts of patients with no signs of heart disease that could not be used for transplantation because of ABO-mismatch were used as NF controls. The majority of donor hearts was obtained from patients who died of intracerebral or subarachnoidal bleedings.
Determination of Isometric Force Generation
Myocardial tissue was obtained during transplantation, stored in ice-cold cardioplegic solution and delivered to the laboratory imme-diately. For biochemical experiments, LV tissue was shock-frozen in liquid nitrogen and stored at Ϫ80°C until further use. For functional experiments, isolated LV trabeculae were mounted in organ baths containing oxygenated Tyrode's solution as described previously. 23 Trabeculae (maximally 1 mm wide) were stretched to the length at which force generation was optimal and electrically stimulated (1 Hz, 37°C), and isometric force (F) was recorded continuously. Developed force was calculated as the difference between systolic and diastolic force. Time to half-maximal relaxation (RT 50 ) and maximal relaxation velocity (ϪdF/dt max ) were calculated. Relative relaxation velocity (RRV) was the ratio of ϪdF/dt max divided by developed force. When diastolic tension was expressed as percentage of baseline, the change in diastolic tension (in mN) was related to developed force at baseline.
Experimental Protocol
Trabeculae were exposed to Fe 3ϩ -nitrilotriacetic acid (Fe 3ϩ -NTA, 100 mol/L) for 5 minutes, and then H 2 O 2 (1 mmol/L) was added for 15 minutes in the continuous presence of Fe 3ϩ -NTA. These concentrations of Fe 3ϩ -NTA/H 2 O 2 produce Ȯ H via the Fenton reaction at concentrations comparable to those that occur in the coronary effluent (and, thus, extracellularly) during the reperfusion of rabbit hearts after 30 minutes of global ischemia. 4 Numbers in parentheses (n) indicate the numbers of patients these parameters were available from. ANP and BNP mRNA expression was determined by real-time PCR in LV samples. ACE-I/AT 1 -Ant indicates angiotensin-converting enzyme inhibitor or angiotension II type 1 antagonist; CI, cardiac index; FS, fractional shortening; LVEDD, LV end-diastolic diameter; LVEF, LV ejection fraction; NYHA, New York Heart Association class; PCWP, pulmonary capillary wedge pressure. *PϽ0.05 vs NF.
oxidation of intracellular NADH and 5-(-6)-chloromethyl-2Ј,7Јdichlorohydrofluorescein (data not shown), a fluorescent dye sensitive to H 2 O 2 and Ȯ H that locates primarily to the mitochondrial matrix, 24 verifying that H 2 O 2 and Ȯ H do not only react extracellularly or at the sarcolemmal membrane of myocytes, but also intracellularly, and presumably also intramitochondrially. The control groups received Fe 3ϩ -NTA alone. After 15 minutes, Ȯ H were washed out, and force generation in response to elevated extracellular [Ca 2ϩ ]([Ca 2ϩ ] o ) was determined (1.8 to 15 mmol/L CaCl 2 ). As mitoK ATP and sarcK ATP blockers, 5-HD (500 mol/L) or HMR-1098 (30 mol/L) were added 20 minutes before Fe 3ϩ -NTA/H 2 O 2 .
For the initial set of experiments ( Figure 1 ), nϭ28 trabeculae from nϭ10 failing hearts (DCM, nϭ6; ICM, nϭ4), and nϭ19 trabeculae from nϭ7 NF hearts were divided into 4 groups, as indicated in Online Table I . For experiments in which the effects of K ATP channel blockers were tested in failing myocardium (Figure 3 ), nϭ19 trabeculae from nϭ5 hearts were divided into 3 groups: (1) Ȯ H alone (nϭ6 trabeculae from 5 hearts); (2) Ȯ H ϩ5-HD (nϭ7/5); and (3) Ȯ HϩHMR-1098 (nϭ6/5).
Western Blot Analysis
For Western blot analysis of human failing and NF myocardium, we used antibodies against Kir6.1 (sc-11224), Kir6.2 (sc-11226), SUR1 (sc-5789), SUR2 (sc-5793), calsequestrin 2 (sc-28275), and cytochrome c (sc-8384; all from Santa Cruz Biotechnology, Santa Cruz, Calif). For more details, see the Online Data Supplement.
Materials
Unless otherwise indicated, agents were from Sigma-Aldrich, Germany. HMR-1098 was kindly provided by Hoechst/Aventis, Germany.
Statistical Analysis
Values are given as meansϮSEM. Statistical analysis was performed using One-Way ANOVA (Online Figures I through III) , Two-way ANOVA for repeated measurements (Figures 1 and 3 
Results

Effects of Ȯ H in Human LV Myocardium
Application of 1 mmol/L H 2 O 2 and 0.1 mmol/L Fe 3ϩ -NTA produces Ȯ H at levels comparable to those occurring in the coronary effluent during ischemia/reperfusion in isolated hearts. 1, 4, 5 LV trabeculae from patients with heart failure or NF controls were exposed to Fe 3ϩ -NTA alone (control) or Fe 3ϩ -NTA/H 2 O 2 for 15 minutes. There were no differences in baseline contractile parameters between NF and failing preparations (Online Table I ). In NF myocardium, systolic force declined and diastolic tension increased in response to Ȯ H (Figure 1A, 1C, and 1D ). This increase was related to a slowing of relative relaxation velocity (RRV) ( Figure 1E ) and, thus, prolongation of time to 50% relaxation (RT50) ( Figure 1F ). The increase of diastolic tension correlated with prolongation of RT 50 and the decline in developed force, respectively ( Figure 1G and 1H ). After washout of Ȯ H, diastolic tension returned to baseline values, whereas developed tension remained depressed ( Figure 1A) , RRV remained decreased and RT 50 prolonged (PϽ0.05 versus control; data not shown). The inotropic response to increased extracellular [Ca 2ϩ ] ([Ca 2ϩ ] o ) was blunted compared to control preparations ( Figure 1I) .
In contrast to NF myocardium, Ȯ H did not reduce systolic force development in failing myocardium ( Figure 1B and  1C) . The Ȯ H-induced increase in diastolic tension and prolongation of RT 50 were less pronounced, and the decrease in RRV was absent in failing compared to NF myocardium ( Figure 1D through 1F) . After Ȯ H washout, no impairment of systolic or diastolic parameters remained, and the response to elevated [Ca 2ϩ ] o was preserved ( Figure 1B and 1J ).
Protein Expression of sarcK ATP in Human LV Myocardium
The cardiac sarcK ATP consists of Kir6.2 and SUR2A. 18 Because overexpression of SUR2A reduced infarct size in mice, 25 we examined whether in human failing myocardium, expression of sarcK ATP may be altered. In LV myocardium from patients with either ICM or DCM, expressions of Kir6.2 and SUR2 were 2.3-and 1.8-fold upregulated, respectively (Figure 2) , with a close correlation between Kir6.2 and SUR2 expressions (rϭ0.69; PϽ0.001; Online Table II ). As an index of hemodynamic load, mRNA expression of atrial and brain natriuretic peptide was increased in failing compared to NF LV myocardium (Table and Online Figure I) . Moreover, activity of aconitase, a mitochondrial enzyme sensitive to oxidative stress, 19, 26 was reduced by 46Ϯ6% in failing versus NF myocardium (PϽ0.001; data not shown). Upregulation of Kir6.2 and SUR2 correlated with elevated atrial natriuretic peptide and brain natriuretic peptide but also decreased aconitase activity (Online Table II ).
Effects of K ATP Channel Inhibition on Ȯ H-Induced Stunning
To evaluate whether sarcK ATP or mitoK ATP are constitutively active in human failing myocardium, we performed a second series of experiments on failing LV myocardium, in which we blocked sarcK ATP or mitoK ATP with HMR-1098 or 5-HD, respectively, 17 during exposure to Ȯ H. Again, Ȯ H did not reduce developed force and only slightly increased diastolic tension in failing myocardium ( Figure 3A and 3B) . The maximum response to elevated [Ca 2ϩ ] o (282Ϯ35% of baseline force; Figure 3C ) was comparable to our initial experi-ments ( Figure 1J; 260Ϯ23%) . Inhibiting mitoK ATP with 5-HD led to a substantial decay of developed force in response to Ȯ H (to 51Ϯ13%; Figure 3A) , which was comparable to the Ȯ H-induced decrease in NF LV myocardium in the absence of 5-HD (38Ϯ8%; Figure 1C ). There was a slight potentiation of the Ȯ H-induced increase in diastolic tension in the presence of 5-HD (PϭNS; Figure 3B ). The maximum response to elevated [Ca 2ϩ ] o was blunted compared to Ȯ H alone ( Figure 3C ). In contrast, inhibition of sarcK ATP did neither affect developed force, diastolic tension, nor the response to elevated [Ca 2ϩ ] o compared to Ȯ H alone ( Figure  3A through 3C ).
Discussion
The "Stunning Paradox" in Human Failing Myocardium
In human NF myocardium, Ȯ H decreased developed force and increased diastolic tension. This was associated with slowing of relaxation and thus, in line with the concept that Ȯ H induce cytosolic Ca 2ϩ overload by inhibiting sarcoplasmic reticulum Ca 2ϩ ATPase and activating reverse-mode Na ϩ /Ca 2ϩ exchanger (NCX). 2, 6, 7 In contrast to predictions from animal models, 10, 11 however, human failing myocardium was resistant to Ȯ H-induced stunning. In a previous study on cardiomyocytes from dogs with heart failure, Ȯ H-induced hypercontracture occurred earlier than in NF myocytes despite similar activity of antioxidant enzymes. 10 Because in heart failure, expression of NCX and its operation in the reverse mode during the action potential are enhanced, it was proposed that this could predispose to Ȯ H-induced Ca 2ϩ overload. 10, 11 In fact, in rabbit myocytes, NCX overexpression shortened the time to Ȯ H-induced hypercontracture. 11 Both studies, 10,11 however, were performed on quiescent myocytes, and Ȯ H-induced stunning was not evaluated.
Regulation of sarcK ATP in Human Failing Myocardium
Protein expression of sarcK ATP was Ϸ2-fold upregulated in LV myocardium from failing hearts, with a close correlation between (1) Kir6.2 and SUR2 expression and (2) the degree of Kir6.2/SUR2 upregulation and LV expression of atrial natriuretic peptide and brain natriuretic peptide, but also the degree of oxidative stress (ie, reduced aconitase activity), indicating that the severity of heart failure may influence sarcK ATP expression. This is in line with data on atrial myocytes from patients with heart failure, in which current density of sarcK ATP was increased and the response to metabolic inhibition accelerated compared to NF hearts. 27 Given that Ȯ H can directly activate sarcK ATP , 21 increased expression of sarcK ATP in failing hearts could have aggravated acute force decline in the presence of Ȯ H because of action potential duration shortening, as suggested by experiments on mice overexpressing SUR2A. 25 In these mice, hypoxia led to an earlier opening of sarcK ATP and shortening of action potential duration during hypoxia, thereby preventing Ca 2ϩ overload and cell death. 25 In human failing myocardium, however, force did not decline at all in response to Ȯ H, and sarcK ATP blockade did not affect force development, arguing against relevant Ȯ H-induced opening of sarcK ATP . The lack of sarcK ATP activation may be explained by (1) an amelioration of energetic dissipation by Ȯ H in failing myocardium and/or (2) impaired metabolic signal generation and transmission from mitochondria to sarcK ATP via creatine kinase, as suggested by a mouse model of heart failure. 28
Role of mitoK ATP in Human LV Myocardium
The mitoK ATP -inhibitor 5-HD aggravated Ȯ H-induced stunning in failing LV myocardium to a degree comparable to NF myocardium in the absence of 5-HD. This suggests that endogenous activation of mitoK ATP protects human failing myocardium from Ȯ H-induced contractile dysfunction. Indeed, Hoskins et al 29 observed that in failing dog myocardium, infarct size was reduced compared to NF controls. Although the underlying mechanisms remained unresolved, they proposed that "chronic cardioprotective adaptations (eg, preconditioning)" in heart failure could account for their unanticipated finding. 29 Although the detailed mechanisms of preconditioning are complex and not entirely resolved yet, 14 -18 many concepts agree that the stimulation of inhibitory G protein (G i )-coupled receptors by endogenous adenosine, bradykinin, and opioids activates a signaling cascade consisting of phosphatidylinositol 3-kinase, Akt, endothelial NO synthase, guanylyl cyclase, protein kinase G, and protein kinase C (PKC) that opens mitoK ATP . This induces slight depolarization of ⌬⌿ m and ROS production at the ETC. ROS, in turn, activate (a second pool of) PKC and redox-sensitive mitogen-activated protein kinase (eg, p38, extracellular signal-regulated kinase 1/2, Akt), which converge on glycogen synthase kinase 3␤ to inhibit opening of the MPTP. 16 Direct interaction of PKC and glycogen synthase kinase 3␤ with mitoK ATP may be critical downstream steps in preventing activation of the MPTP and thus, cell death. 16 Indeed, many of these signaling components are activated in heart failure. Besides elevated plasma levels of ␤-endorphin and adenosine, expression of G i , 30 and phosphorylation of Akt, p38, ERK1/2, and glycogen synthase kinase 3␤ are increased in human failing myocardium. 31 Furthermore, ROS are elevated 19 and can directly activate mitoK ATP . 20 MitoK ATP opening triggers mitochondrial ROS production from complex I, 32 a site also responsible for ROS production in heart failure. 33 Recently, this was proposed to constitute a positive feedback loop ("mitoK ATP -dependent mitoK ATP opening") that may be responsible for the memory effect of preconditioning. 34 An important component of this feedback loop is the translocation of PKC to mitochondria, 34 and PKC translocation from the cytosol to the particulate fraction was also observed in human failing myocardium. 35 In this context, our observation that inhibition of mitoK ATP abolishes the resistance of failing myocardium to Ȯ Hinduced stunning leads us to propose that human failing myocardium is endogenously preconditioned.
Clinical Implications
Patients with type 2 diabetes are frequently treated with sulfonylurea drugs, eg, glibenclamide, which inhibit both sarcK ATP and mitoK ATP . 17 In patients with diabetes, coronary artery disease, and heart failure (LV ejection fraction of Ϸ45%), treatment with glibenclamide (but not insulin) induced contractile dysfunction during stress-induced ischemia. 36 Because these patients were not intentionally preconditioned, this implies that in patients with heart failure, a certain degree of ischemic tolerance occurred that was sensitive to glibenclamide. Because sarcK ATP channels are un-likely to account for the glibenclamide effect in this situation, 37 inhibition of mitoK ATP would be the likeliest explanation. This may even have prognostic implications, because in patients undergoing angioplasty for myocardial infarction (LV ejection fraction, 47% to 55%), the use of sulfonylurea drugs was associated with an increased risk of in-hospital mortality unrelated to arrhythmias. 38 Together with our present results, these data suggest that in patients with heart failure and diabetes, the treatment with glibenclamide may impair myocardial tolerance to ischemia/reperfusion by inhibiting mitoK ATP channels. Second-generation sulfonylureas, such as gliclazide and glimepiride, do not interfere with mitoK ATP activation 39, 40 and, thus, may be more favorable in these patients.
Limitations
The existence of mitoK ATP has been challenged based on the observation that diazoxide inhibits succinate dehydrogenase (complex II of the ETC), which resembles an alternative (K ATP -independent) mechanism to uncouple respiration and increase ROS production. 14, 15 Moreover, 5-HD is a fatty acid that (after activation to 5-HD-coenzyme A) could deliver electrons to the ETC via ubiquinone and by this mechanism, could bypass diazoxide-induced blockade of complex II. 15 It is unlikely, however, that 5-HD impaired systolic force development in failing myocardium in the presence of Ȯ H by this mechanism, because in a rat model of ischemia/reperfusion, boosting electron delivery to the ETC by exogenous succinate improved (rather than deteriorated) force recovery at reperfusion 41 (during which Ȯ H are released 1 ).
